# Effect of High Dose Ciclesonide on Asthma Control

> **NCT01455194** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 520 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** Ciclesonide

## Key facts

- **NCT ID:** NCT01455194
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455194, "Effect of High Dose Ciclesonide on Asthma Control". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01455194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*